Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
http://www.priceseries.com/trade/SENS-Senseonics-Holdings-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2022013120220211.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments